QUIA PHARMA AB (STU:99B0) GF Value Rank: 2 (As of Aug. 12, 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:99B0 QUIA PHARMA AB STU:99B0
4 GF Score
Price €0.00
! 3 Warning Signs
View Full Analysis

What is QUIA PHARMA AB GF Value Rank?

QUIA PHARMA AB STU:99B0 4 GF Value Rank is 2 as of Aug. 12, 2026, which is at its 10-year median of 2.00. GuruFocus rates STU:99B0 with a GF Score™ of 4/100. The stock has 3 warning signs investors should review.

QUIA PHARMA AB has the GF Value Rank of 2.

GF Value Rank evaluates the exclusive GuruFocus valuation and performance of a stock, rated on a scale from 1 to 10. It is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.

GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).

We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.

After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.

A higher score indicates a stock with a relatively low valuation and substantial potential for outperformance. Conversely, a lower score often reflects stocks that are either highly overvalued or deeply undervalued, both of which tend to underperform.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

QUIA PHARMA AB GF Value Rank Related Terms

STU:99B0 vs VRTX, REGN, ALNY: GF Value Rank Comparison

For the Biotechnology subindustry, QUIA PHARMA AB's GF Value Rank, along with its competitors' market caps and GF Value Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

QUIA PHARMA AB GF Value Rank vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, QUIA PHARMA AB's GF Value Rank distribution charts can be found below:

* The bar in red indicates where QUIA PHARMA AB's GF Value Rank falls into.


STU:99B0
4GF Score
QUIA PHARMA AB STU:99B0
GF Value Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Value Rank →
What does a GF Value Rank of 2 mean?
QUIA PHARMA AB (STU:99B0) has a GF Value Rank of 2 as of Aug. 12, 2026. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on QUIA PHARMA AB and its competitors. This is near median its historical median of 2.00. Over the past decade, QUIA PHARMA AB's GF Value Rank has ranged from 2.00 to 2.00.
Is QUIA PHARMA AB's GF Value Rank too high?
QUIA PHARMA AB's current GF Value Rank of 2 is near median its 10-year median of 2.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 2.00. Overall, QUIA PHARMA AB has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does QUIA PHARMA AB's GF Value Rank compare to VRTX and REGN?
QUIA PHARMA AB's GF Value Rank of 2 can be compared against companies in the Biotechnology industry. Historically, QUIA PHARMA AB's own GF Value Rank has ranged from 2.00 to 2.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Value Rank for a Biotechnology company?
A good GF Value Rank depends on the Biotechnology industry context. However, GF Value Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Value Rank mean?
A high GF Value Rank can signal that a stock is expensive relative to its fundamentals. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on QUIA PHARMA AB and its competitors. QUIA PHARMA AB's current GF Value Rank is 2, which is near median its own 10-year median of 2.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is QUIA PHARMA AB stock overvalued right now?
QUIA PHARMA AB (STU:99B0) has a current GF Value Rank of 2. The current GF Value Rank is 2, which is near median its 10-year median of 2.00. QUIA PHARMA AB's overall GF Score™ is 4/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Value Rank calculated?
GF Value Rank is calculated from a company's financial statements. For QUIA PHARMA AB (STU:99B0), the current GF Value Rank is 2 as of Aug. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

QUIA PHARMA AB Business Description

Address Virdings Alle 32 B, Uppsala, SWE, 754 50
QUIA PHARMA AB is a development company for pharmaceuticals based on a patented drug delivery platform, Uni-Qleaver. The company develops improved and patentable forms of drugs under development or already approved by pharmaceutical authorities. These refined and enhanced forms of medicine are based on the Company's exceptional and patented technology platform. In addition to this, the Company offers multinational sales of omega-3, astaxin and collagen through Amazon.
4GF Score

Get the complete analysis for STU:99B0

GF Value Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.00
Price